Mark Connor Selected Research

N'- ((E)- (2- hydroxynaphthalen- 1- yl)methylidene)- 3- (2- methyl- 1H- benzimidazol- 1- yl)propanehydrazide

4/2009

Shadows across mu-Star? Constitutively active mu-opioid receptors revisited.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark Connor Research Topics

Disease

8	Pain (Aches) 01/2022 - 03/2002
7	Hypothermia 01/2022 - 08/2015
6	Inflammation (Inflammations) 12/2019 - 03/2002
4	Chronic Pain 01/2022 - 04/2005
3	Pica (Geophagia) 11/2020 - 10/2017
3	Bradycardia 10/2017 - 09/2015
2	Epilepsy (Aura) 01/2022 - 01/2022
2	Substance-Related Disorders (Drug Abuse) 01/2021 - 05/2015
2	Migraine Disorders (Migraine) 01/2019 - 11/2008
2	Glioma (Gliomas) 04/2009 - 07/2003
1	Mental Disorders (Mental Disorder) 03/2022
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 03/2022
1	Nervous System Diseases (Neurological Disorders) 01/2022
1	Absence Epilepsy (Childhood Absence Epilepsy) 01/2022
1	Neoplasms (Cancer) 01/2021
1	Neuralgia (Stump Neuralgia) 01/2021
1	Seizures (Absence Seizure) 01/2021
1	Constipation 01/2020
1	Nausea 01/2019
1	Neuroinflammatory Diseases 01/2019
1	Tourette Syndrome (Tourette's Syndrome) 01/2019
1	Cognitive Dysfunction 01/2019
1	Psychotic Disorders (Schizoaffective Disorder) 01/2019
1	Vomiting 01/2019
1	Anorexia Nervosa 01/2019
1	Multiple Sclerosis 01/2019
1	Headache (Headaches) 09/2012
1	Gout 01/2009
1	Myalgia 10/2005
1	Arthritis (Polyarthritis) 04/2005
1	Neuroblastoma 07/2003

Drug/Important Bio-Agent (IBA)

4	Opioid Analgesics (Opioids)IBA 01/2021 - 11/2008
3	Analgesics (Analgesic Drugs)IBA 01/2022 - 11/2008
3	CannabinoidsIBA 11/2020 - 10/2017
3	Pharmaceutical PreparationsIBA 01/2019 - 11/2008
2	T-Type Calcium Channels (T-Type Calcium Channel)IBA 01/2022 - 01/2022
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2022 - 11/2020
2	Opioid Receptors (Opioid Receptor)IBA 01/2021 - 01/2020
2	LigandsIBA 01/2020 - 11/2008
2	GTP-Binding Proteins (G-Protein)IBA 01/2020 - 09/2012
2	CB2 Cannabinoid ReceptorIBA 12/2019 - 01/2019
2	cumyl-PINACAIBA 02/2019 - 10/2017
1	Psilocybin (Psilocibin)IBA 03/2022
1	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 03/2022
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	Dronabinol (THC)FDA LinkGeneric 01/2022
1	Tapentadol FDA Link 01/2022
1	Morphine (MS Contin)FDA LinkGeneric 01/2022
1	Illicit Drugs (Recreational Drugs)IBA 01/2022
1	Oxycodone (Oxycontin)FDA LinkGeneric 01/2022
1	Cannabinoid Receptor AgonistsIBA 01/2021
1	Pregabalin (Lyrica)FDA Link 01/2021
1	Gabapentin (Neurontin)FDA LinkGeneric 01/2021
1	EpitopesIBA 01/2021
1	5F-CUMYL-PICAIBA 11/2020
1	5F-CUMYL-P7AICAIBA 02/2019
1	Tryptamines (Triptans)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	methyl (1- (5- fluoropentyl)- 1H- indazole- 3- carbonyl)valinateIBA 01/2016
1	AB-FUBINACAIBA 09/2015
1	N- (1- amino- 3- methyl- 1- oxobutan- 2- yl)- 1- pentyl- 1H- indazole- 3- carboxamideIBA 09/2015
1	1-pentyl-3-(1-naphthoyl)indoleIBA 08/2015
1	terameprocolIBA 12/2014
1	AcetoneIBA 12/2014
1	TRPA1 Cation ChannelIBA 01/2014
1	CationsIBA 01/2014
1	Serotonin (5 Hydroxytryptamine)IBA 09/2012
1	Serotonin ReceptorsIBA 09/2012
1	mu Opioid Receptors (mu Opioid Receptor)IBA 04/2009
1	N'- ((E)- (2- hydroxynaphthalen- 1- yl)methylidene)- 3- (2- methyl- 1H- benzimidazol- 1- yl)propanehydrazideIBA 04/2009
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2009
1	Uric Acid (Urate)IBA 01/2009
1	Xanthine OxidaseIBA 01/2009
1	HypoxanthineIBA 01/2009
1	EnzymesIBA 01/2009
1	Allopurinol (Remid)FDA LinkGeneric 01/2009
1	Adenosine (Adenocard)FDA LinkGeneric 01/2009
1	Sumatriptan (Imigran)FDA LinkGeneric 11/2008
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2006
1	Ion Channels (Ion Channel)IBA 10/2005
1	Bradykinin Receptors (Bradykinin Receptor)IBA 04/2005
1	Bradykinin B1 ReceptorIBA 04/2005
1	calycanthineIBA 07/2003
1	gamma-Aminobutyric Acid (GABA)IBA 07/2003
1	Calcium Channels (Calcium Channel)IBA 07/2003
1	CalciumIBA 07/2003
1	ProstaglandinsIBA 03/2002

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2019 - 11/2008
2	Induced Hypothermia 10/2017 - 09/2015
1	Therapeutics 05/2015